BALTECH is developing an Intelligent diagnostic virtual human visualization platform/database (ID-VHVP) for surgical skills preparation and practice; medical education, training and experiential diagnostics and digital medical record immersion.
Bayer is an international, research-based group with major businesses in health care and nutrition. Employing 118,900 people worldwide, and around 1100 in Australia/New Zealand, the Bayer Group has operations in nearly all countries of the globe.
BCAL Diagnostics is commercialising a simple blood test to detect breast cancer earlier and more accurately. The BCAL Dx approach could revolutionise detection of breast cancer as the technology enables accessibility to a routine method of screening for women of all ages and has multiple applications in screening, diagnostics, treatment and monitoring.
Bellberry Limited is a national, private not-for-profit organisation providing streamlined scientific and ethical review of human research projects across Australia. They aim to promote and improve the welfare of research participants and the quality, efficiency and effectiveness of research.
Bespoke Medical Innovations Pty Ltd is an Australian based medical innovation company specialising in bespoke or custom solutions within the medical field. The company uses state of the art technologies that include 3D imaging, 3D printing, simulation technology, anatomical scanning, cloud computing, and custom-moulding techniques.
Beta Therapeutics is an Australian biotechnology company developing first in class treatments for diabetes, covering type 1 diabetes, type 2 diabetes, and other diseases driven by local inflammation.
Bio-Nexus provides a pre-hospital solution for civilian and military medical services and providers.
Bio101 provides financial solutions to a range of Australian life science companies ranging from small start-ups to ASX listed companies. The company's services range from CFO services, Company Secretary services, Taxation (including R&D), ASIC compliance to bookkeeping and other back office administration.
Founded in 2014, BioClub is the largest next-generation innovation platform for the medical and healthcare industry in China, aiming to establish an ecosystem that accelerates the translation of innovative ideas and research outcomes into real-life medical services and products.
BioCurate Pty Ltd is a collaboration between the University of Melbourne and Monash University, two of Australia's top universities for biomedical and pharmaceutical research.
Biomedical Research Victoria (BioMedVic) is the peak body for the organisations that make up this internationally-recognised research community, providing a collective voice for advocacy and a structure for promoting collaboration and innovation.
The BioMelbourne Network is a not-for-profit membership association for organisations engaged in biotechnology, medical technology and health innovation in the state of Victoria. Their role is to foster links between companies, research organisations, financial markets and government, creating an environment for greater collaboration and prosperity.
Bionic Vision Technologies is dedicated to developing effective and innovative implantable retinal prostheses (“bionic eyes”) for patients who have lost vision due to Retinitis Pigmentosa. Their approach is based on proven technology and data from early prototype investigations that form part of a core product pipeline.
Bioregulatory Consulting (BRC) provides a specialised regulatory and development service to the biotechnology and pharmaceutical industries. BRC is a privately held company, based in Melbourne, which was founded in February 2002.
Bioshares is Australia's leading biotech stock report. Bioshares delivers independent investment research to investors on Australian biotech, pharmaceutical and healthcare companies.
Blue Curve are medical device design and safety engineering experts, working exclusively with medical devices. From lab bench to market, having a specialist focus allows Blue Curve to go deep with your product.
At Boehringer Ingelheim, the purpose is simply to ‘Make More Health’ - for patients, people and community.
Brien Holden Vision Institute believes that sight is a fundamental right for everyone, everywhere. The Institute develops new solutions for vision care, especially refractive error, and work to eliminate vision impairment and avoidable blindness, thereby improving quality of life for people in need and helping to reduce disability and poverty.
Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.